KP
Kaveri Pohlman Clear Street Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
13
Avg Return
Past Year
Past Year
2.3%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
88.2%
Neutral
11.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $70 |
265%
upside
| 1 | -8.5% |
0
%
| 11 Mar ‘26 3 months ago |
|
|
|
Buy
Maintained
| $20 |
39%
upside
| 1 | -11% |
0
%
| 6 Mar ‘26 3 months ago |
|
|
|
Hold
Downgraded
| $58 |
0%
downside
| 3 | +15% |
0
%
| 20 Jan ‘26 4 months ago |
|
|
|
Hold
Downgraded
| $12 |
13%
downside
| 2 | -60% |
0
%
| 20 Jan ‘26 4 months ago |
|
|
|
Buy
Initiated
| $12 |
610%
upside
| 1 | -20% |
0
%
| 30 Dec ‘25 5 months ago |
|
|
|
Buy
Maintained
| $99 |
130%
upside
| 1 | -17% |
0
%
| 9 Dec ‘25 6 months ago |
|
|
|
Buy
Initiated
| $200 |
72%
upside
| 1 | +36% |
0
%
| 5 Dec ‘25 6 months ago |
|
|
|
Buy
Initiated
| $25 |
55%
upside
| 1 | +18% |
0
%
| 25 Nov ‘25 6 months ago |
|
|
|
Buy
Maintained
| $21 |
43%
upside
| 1 | -1% |
0
%
| 14 Nov ‘25 7 months ago |
|
|
|
Buy
Initiated
| $18 |
389%
upside
| 1 | +36% |
0
%
| 13 Nov ‘25 7 months ago |
|
|
|
Buy
Initiated
| $29 |
348%
upside
| 1 | -33% |
0
%
| 22 Oct ‘25 7 months ago |
|
|
|
Buy
Initiated
| $11 |
21%
downside
| 1 | +350% |
0
%
| 1 Oct ‘25 8 months ago |
|
|
|
Buy
Maintained
| $46 |
33%
downside
| 1 | +80% |
0
%
| 17 Sep ‘25 9 months ago |
|
|
|
Buy
Initiated
| $32 |
6%
upside
| 1 | +6.9% |
0
%
| 25 Jun ‘25 11 months ago |
|